EBNEO Commentary: Efficacy and safety of enteral recombinant human insulin in preterm infants: A randomised clinical trial

Acta Paediatr. 2022 Nov;111(11):2242-2243. doi: 10.1111/apa.16479. Epub 2022 Jul 16.

Authors

Ikhwan Halibullah¹, Peter G Davis^{1

2

3}, Brett J Manley^{1

2

3}

Affiliations

¹ Newborn Research, The Royal Women's Hospital, Melbourne, Victoria, Australia.
² Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.
³ Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

PMID: 35841282
DOI: 10.1111/apa.16479

No abstract available

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Enterocolitis, Necrotizing*
Humans
Infant
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Insulins*

Substances

Insulins